ASGENIA is a pharmaceutical services company specialized in pharmacovigilance. Established in 2013, it has positioned itself as a leader in the industry, offering its expertise to national and international partners for the management of pharmacovigilance activities in compliance with industry regulations. As an attractive investment opportunity, ASGENIA's decade-long experience in pharmacovigilance makes it a promising partner for investors seeking a foothold in the pharmaceutical sector. With its strong reputation and extensive industry knowledge, ASGENIA presents an appealing prospect for venture capital investment.
There is no investment information
No recent news or press coverage available for ASGENIA.